IRCT20170408033308N2
Completed
Phase 3
The effects of Crocin supplementation on metabolic parameters, systemic inflammation and AMP- activated protein kinase, TNF-a and NF-Kß in patients with type 2 diabetes.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Patients with type 2 diabetes.
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged 30\-70 years old
- •Clinical diagnosis of type 2 diabetes (for at least 1 year)
- •Body mass index (BMI) 18\.5\-30 kg/m2
Exclusion Criteria
- •Having liver, kidney, inflammatory and pulmonary diseases;
- •Alcohol\-drug abuse;
- •Pregnancy and lactation;
- •Insulin injection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of Crocin and Metformin in patients with type 2 diabetesIRCT20170611034458N2Esfahan University of Medical Sciences60
Recruiting
Phase 3
Effect of crocin supplementation in patients with diabetic nephropathyDiabetic nephropathy.Diabetes mellitus due to underlying condition with diabetic nephropathyE08.21IRCT20170611034458N3Esfahan University of Medical Sciences60
Recruiting
Phase 2
Efficacy and Safety of Crocin Supplementation in Patients With Central SerousChorioretinopathy (CSCR)Central serous chorioretinopathy.Central serous chorioretinopathyH35.71IRCT20110811007297N7Shiraz University of Medical Sciences40
Not yet recruiting
Phase 3
Effect of crocin on depression induced by amphetamine withdrawalIRCT20160804029191N3Mashhad University of Medical Sciences60
Recruiting
Phase 2
Evaluation of the effect of crocin in the treatment of cystoid macular edema secondary to retinitis pigmentosaIRCT20201219049753N2Mashhad University of Medical Sciences20